Sector Update: Health Care Stocks Ease Monday Afternoon

Health care stocks were lower Monday afternoon with the NYSE Health Care Index fractionally lower and the Health Care Select Sector SPDR Fund (XLV) down 0.1%.

The iShares Biotechnology ETF (IBB) rose 0.6%.

In corporate news, Hims & Hers Health HIMS surged 29% after the company announced it's offering GLP-1 injections starting at $199 a month, using compounded versions of the active ingredient in weight loss drugs sold by Novo Nordisk (NVO) and Eli Lilly (LLY). Novo Nordisk shares rose 1.3%, and Eli Lilly was up 1.5%.

NKGen Biotech NKGN surged 54.5% after it said Monday its safety review committee has cleared the company's expanded SNK01 cell therapy to progress into phase 2 clinical development in Alzheimer's disease.

Atara Biotherapeutics ATRA spiked 4.8% after it said Monday it has filed a biologics license application with the US Food and Drug Administration for tabelecleucel to treat people with Epstein-Barr virus positive post-transplant lymphoproliferative disease.